Boditech Med Future Growth

Future criteria checks 2/6

Boditech Med is forecast to grow earnings and revenue by 16.6% and 15.2% per annum respectively. EPS is expected to grow by 14% per annum. Return on equity is forecast to be 16.8% in 3 years.

Key information

16.6%

Earnings growth rate

14.0%

EPS growth rate

Medical Equipment earnings growth	35.6%
Revenue growth rate	15.2%
Future return on equity	16.8%
Analyst coverage	Low
Last updated	23 Oct 2024

Recent future growth updates

No updates

Recent updates

Risks Still Elevated At These Prices As Boditech Med Inc. (KOSDAQ:206640) Shares Dive 26%

Oct 14

Boditech Med (KOSDAQ:206640) Has More To Do To Multiply In Value Going Forward

Oct 11

Does Boditech Med (KOSDAQ:206640) Have A Healthy Balance Sheet?

Sep 13

Investor Optimism Abounds Boditech Med Inc. (KOSDAQ:206640) But Growth Is Lacking

Jul 12

Boditech Med Inc. (KOSDAQ:206640) Shares Fly 49% But Investors Aren't Buying For Growth

Apr 16

Here's Why I Think Boditech Med (KOSDAQ:206640) Might Deserve Your Attention Today

Apr 13

Could The Market Be Wrong About Boditech Med Inc. (KOSDAQ:206640) Given Its Attractive Financial Prospects?

Mar 01

Boditech Med (KOSDAQ:206640) Seems To Use Debt Rather Sparingly

Jan 18

Here's Why I Think Boditech Med (KOSDAQ:206640) Is An Interesting Stock

Dec 28

Did Business Growth Power Boditech Med's (KOSDAQ:206640) Share Price Gain of 193%?

Dec 08

Boditech Med Inc. (KOSDAQ:206640) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?

Nov 18

Earnings and Revenue Growth Forecasts

KOSDAQ:A206640 - Analysts future estimates and past financials data (KRW Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
12/31/2026	202,533	47,600	30,650	45,050	3
12/31/2025	174,500	41,300	27,750	39,950	3
12/31/2024	149,900	37,800	27,000	36,000	2
6/30/2024	139,134	30,438	23,301	32,087	N/A
3/31/2024	137,839	27,045	24,370	31,799	N/A
12/31/2023	134,219	25,947	28,670	34,300	N/A
9/30/2023	128,155	25,871	25,386	30,349	N/A
6/30/2023	121,041	22,609	26,367	35,776	N/A
3/31/2023	110,218	21,117	12,792	27,075	N/A
12/31/2022	118,077	24,152	6,213	23,068	N/A
9/30/2022	126,066	25,041	2,411	22,442	N/A
6/30/2022	142,187	33,340	1,790	24,706	N/A
3/31/2022	159,953	41,457	13,918	32,618	N/A
12/31/2021	157,708	44,367	31,516	49,927	N/A
9/30/2021	177,616	56,048	44,483	59,441	N/A
6/30/2021	174,334	56,018	54,358	61,535	N/A
3/31/2021	163,625	54,389	50,272	57,354	N/A
12/31/2020	144,131	45,489	40,352	44,643	N/A
9/30/2020	106,463	31,274	29,505	33,510	N/A
6/30/2020	84,712	21,267	14,159	18,069	N/A
3/31/2020	70,140	11,342	14,883	18,601	N/A
12/31/2019	72,799	11,650	12,172	17,242	N/A
9/30/2019	71,903	4,048	12,754	17,817	N/A
6/30/2019	71,815	772	8,743	14,094	N/A
3/31/2019	70,810	853	3,318	8,568	N/A
12/31/2018	66,204	-1,691	1,615	5,315	N/A
9/30/2018	62,113	-3,510	-7,339	-3,393	N/A
6/30/2018	55,175	-4,206	-6,881	-2,743	N/A
3/31/2018	52,908	-3,880	N/A	1,648	N/A
12/31/2017	52,594	-2,148	N/A	887	N/A
9/30/2017	52,703	6,400	N/A	6,164	N/A
6/30/2017	55,832	9,627	N/A	8,619	N/A
3/31/2017	58,211	11,575	N/A	9,745	N/A
12/31/2016	54,974	12,621	N/A	11,791	N/A
9/30/2016	50,911	7,427	N/A	13,133	N/A
6/30/2016	47,053	255	N/A	13,249	N/A
3/31/2016	41,915	-589	N/A	10,116	N/A
12/31/2015	39,821	-1,970	N/A	9,632	N/A
12/31/2013	22,956	5,412	N/A	5,268	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: A206640's forecast earnings growth (16.6% per year) is above the savings rate (2.7%).

Earnings vs Market: A206640's earnings (16.6% per year) are forecast to grow slower than the KR market (29% per year).

High Growth Earnings: A206640's earnings are forecast to grow, but not significantly.

Revenue vs Market: A206640's revenue (15.2% per year) is forecast to grow faster than the KR market (9.8% per year).

High Growth Revenue: A206640's revenue (15.2% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: A206640's Return on Equity is forecast to be low in 3 years time (16.8%).

Boditech Med Future Growth

Future criteria checks 2/6

Key information

Recent future growth updates

Recent updates

Investor sentiment improves as stock rises 16%

Boditech Med Inc. (KOSDAQ:A206640) announces an Equity Buyback for KRW 3,000 million worth of its shares.

Risks Still Elevated At These Prices As Boditech Med Inc. (KOSDAQ:206640) Shares Dive 26%

Investor sentiment deteriorates as stock falls 17%

Boditech Med (KOSDAQ:206640) Has More To Do To Multiply In Value Going Forward

Does Boditech Med (KOSDAQ:206640) Have A Healthy Balance Sheet?

Investor sentiment deteriorates as stock falls 16%

Investor Optimism Abounds Boditech Med Inc. (KOSDAQ:206640) But Growth Is Lacking

SphingoTec GmbH Introduces Kidney Function Biomarker penKid Together with Boditech Med Inc. At the 42nd AKI & CRRT Course in Vicenza

Upcoming dividend of ₩150 per share at 0.7% yield

Third quarter 2023 earnings released: EPS: ₩420 (vs ₩266 in 3Q 2022)

Investor sentiment improves as stock rises 17%

Investor sentiment improves as stock rises 25%

Investor sentiment improves as stock rises 19%

Full year 2022 earnings released: EPS: ₩1,080 (vs ₩1,937 in FY 2021)

Investor sentiment improved over the past week

Upcoming dividend of ₩200 per share

Boditech Med Inc. (KOSDAQ:A206640) announces an Equity Buyback for KRW 5,000 million worth of its shares.

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Upcoming dividend of ₩200 per share

Third quarter 2021 earnings released: EPS ₩624 (vs ₩619 in 3Q 2020)

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

Boditech Med Inc. (KOSDAQ:206640) Shares Fly 49% But Investors Aren't Buying For Growth

Boditech Med Inc. (KOSDAQ:A206640) announces an Equity Buyback for KRW 3,000 million worth of its shares.

Here's Why I Think Boditech Med (KOSDAQ:206640) Might Deserve Your Attention Today

Investor sentiment improved over the past week

Could The Market Be Wrong About Boditech Med Inc. (KOSDAQ:206640) Given Its Attractive Financial Prospects?

Investor sentiment deteriorated over the past week

New 90-day low: ₩18,200

Boditech Med Inc., Annual General Meeting, Mar 29, 2021

Boditech Med (KOSDAQ:206640) Seems To Use Debt Rather Sparingly

New 90-day low: ₩21,000

Here's Why I Think Boditech Med (KOSDAQ:206640) Is An Interesting Stock

Investor sentiment deteriorated over the past week

New 90-day low: ₩23,650

Did Business Growth Power Boditech Med's (KOSDAQ:206640) Share Price Gain of 193%?

New 90-day low: ₩23,950

Boditech Med Inc. (KOSDAQ:206640) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?

Market pulls back on stock over the past week

Market bids up stock over the past week

Choi Eui Yul and three related parties acquired 27% stake in Boditech Med Inc. (KOSDAQ:A206640).

Kim Jae Hak and 11 related parties acquired 11.66% stake in Boditech Med Inc. (KOSDAQ:A206640).

New 90-day high - ₩29,150

Earnings and Revenue Growth Forecasts

Analyst Future Growth Forecasts

Earnings per Share Growth Forecasts

Future Return on Equity

Discover growth companies